SLC2A1 and rheumatoid arthritis: Collectively, USP5 stabilized METTL14-mediated m6A modification of GLUT1 by inhibiting the ubiquitination of METTL14, thereby enhancing glycolysis and inflammatory activation in RA-FLSs.